Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Dec 2022 for BriaCell Therapeutics Corp., €121k.
Filing timeline
BuySaleJamieson Bondarenko
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+45.6%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +30.0%Entry US$45.00 · Close at T+365 US$58.50
- -21.4%Entry US$51.00 · Close at T+365 US$40.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jamieson Bondarenko: trading record in brief
Jamieson Bondarenko appears in our data through filings on BriaCell Therapeutics Corp. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 20 December 2022 and the latest from 28 December 2022.
Every open-market trade on record is a purchase: 2 purchases worth €231k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 28 December 2022 came the latest disclosure, an open-market purchase for €121k in BriaCell Therapeutics Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jamieson Bondarenko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
28,000 shares@ US$4.5852.1% of flowCommon SharesSEC:0001493152-22-036669:0
Canonical exit: 28 Mar 2023 (T+90)
22,000 shares@ US$5.3547.9% of flowCommon SharesSEC:0001493152-22-036060:0
Canonical exit: 20 Mar 2023 (T+90)
2 of 2 declarations
